英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
esfreer查看　esfreer　在百度字典中的解释百度英翻中〔查看〕
esfreer查看　esfreer　在Google字典中的解释Google英翻中〔查看〕
esfreer查看　esfreer　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Signatera – Circulating Tumor DNA Blood Test | Natera
    Signatera™ is designed to detect ctDNA of somatic and truncal variants to optimize sensitivity Tumor-informed method enables filtering of CHIP mutations to decrease false positive rates Once the patient’s personalized test has been designed, only a blood sample is needed each subsequent time
  • Signatera Test. Is it truly helpful and worthwhile?
    "The Signatera™ Residual Disease Test is a custom-built blood test for people who have been diagnosed with breast cancer or other solid tumors Signatera™ can detect molecular residual disease (MRD) in the form of circulating tumor DNA—small fragments of DNA released by cancer cells "
  • Every Cancer Patient Needs To Know About The Signatera Test - Robinson MD
    The Signatera™ test looks for the DNA of YOUR cancer in your blood to detect residual or recurrent cancer They do this by making a lab assay using the tissue specimen from your cancer biopsy or surgical excision
  • What is Signatera? - Colontown University
    Signatera is a new blood test that can identify molecular residual disease (MRD), or recurrent cancer, sooner than existing methods by detecting the presence of circulating tumor DNA (ctDNA) Signatera is a custom-designed test that is generated based on each patient’s unique set of tumor mutations
  • Ask the Experts About Circulating Tumor DNA in the Management of Cancer
    The Signatera test is best used serially (every 3 months) to look for residual cancer - in some situations the detection of ctDNA moves above and below the threshold of detection possible reflecting the bodies immune systems effort to eradicate the cancer
  • Natera Announces Broad Clinical Launch of Ultra-Sensitive Signatera . . .
    Signatera is a personalized, tumor-informed, molecular residual disease test for patients previously diagnosed with cancer Custom-built for each individual, Signatera uses circulating tumor DNA to detect and quantify cancer left in the body, identify recurrence earlier than standard of care tools, and help optimize treatment decisions
  • Signatera FAQ | Natera
    What is Signatera™ and what does it test for? Signatera™ is a personalized, tumor-informed assay optimized to detect circulating tumor DNA (ctDNA) for molecular residual disease (MRD) assessment, treatment response monitoring, and early recurrence monitoring
  • After a Signatera test. What are your options?
    "What is Signatera™ and what does it test for? Signatera™ is a personalized, tumor-informed assay optimized to detect circulating tumor DNA (ctDNA) for molecular residual disease (MRD) assessment, treatment response monitoring, and early recurrence monitoring "
  • Natera’s cancer detection test wins extended Medicare coverage
    Signatera is a personalised MRD test that uses circulating tumour DNA to detect and quantify cancer left in the body MRD tests are used in patients previously diagnosed with cancer to see whether treatment has been successful
  • Natera mRNA Testing for Testicular Cancer: A Patient’s Guide
    The Natera Signatera test provides personalized, highly sensitive monitoring for testicular cancer: Using ctDNA analysis, it detects minimal residual disease (MRD) and recurrence earlier than traditional methods, allowing for timely intervention and personalized treatment strategies





中文字典-英文字典  2005-2009